MedTrace Logo

Stellarex Vascular E-Registry

NCT02769273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1900

Last updated 2025-08-14

No results posted yet for this study

Summary

Prospective, international, multi-center, single arm, observational study to continue to assess the treatment by the Stellarex™ OTW Drug-coated Angioplasty Balloon in superficial femoral and/or popliteal arteries according to the Instructions for Use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution's standard practice.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Percutaneous Transluminal Angioplasty

Sponsors & Collaborators

  • Spectranetics Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2021-10-31
Completion
2021-12-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02769273 on ClinicalTrials.gov